QC
AGN

QCM Cayman’s Allergan plc AGN Stock Holding History

QCM Cayman’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,806
Closed -$301K – 186
2018
Q2 		$301K Buy
+1,806
New +$290K 1.4% 27
2017
Q3 		– Sell
-880
Closed -$214K – 252
2017
Q2 		$214K Sell
880
-3,116
-78% -$732K 0.49% 108
2017
Q1 		$955K Buy
+3,996
New +$931K 0.18% 133
2015
Q2 		– Sell
-1,519
Closed -$452K – 273
2015
Q1 		$452K Buy
+1,519
New +$433K 0.24% 72
2014
Q4 		– Sell
-2,282
Closed -$551K – 318
2014
Q3 		$551K Buy
+2,282
New +$511K 0.13% 66
2014
Q2 		– Sell
-3,110
Closed -$640K – 373
2014
Q1 		$640K Buy
+3,110
New +$616K 0.14% 89

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

QCM Cayman's AGN Position: Q3 2018 in Review

QCM Cayman sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 1,806 shares — an estimated $301K sold.

QCM Cayman first reported a position in AGN in Q1 2014 and held it in 6 quarters. The position peaked at $955K in Q1 2017. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

  • QCM Cayman reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
  • QCM Cayman sold 1,806 Allergan plc shares in Q3 2018, an estimated $301K.
  • QCM Cayman first reported a position in Allergan plc in Q1 2014 and held it in 6 quarters.
  • QCM Cayman's Allergan plc position peaked at $955K in Q1 2017.
  • 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on QCM Cayman's 13F filing for Q3 2018, filed 14 Nov 2018.